Literature DB >> 33616136

Recent progress of redox-responsive polymeric nanomaterials for controlled release.

Peng-Hao Hsu1, Adah Almutairi2.   

Abstract

Redox-responsive polymeric nanomaterials (PNMs) have been attractive research targets for drug delivery systems because disturbed levels of redox molecules are associated with the progression of various diseases. To enable PNMs to target biorelevant redox molecules, including reactive oxygen species (ROS), glutathione (GSH) and hydrogen sulfide (H2S), appropriate responsive moieties have to be installed within the polymer structure. Upon application of redox stimuli, redox-responsive PNMs undergo structural changes to release encapsulated payloads. Chalcogen ether, thioketal and arylboronic ester have been widely incorporated into the structure of ROS-responsive PNMs. While disulfide is commonly utilized in GSH-responsive PNMs, azide is a newly explored responsive motif targeting H2S selectively. Diselenide, on the other hand, is a group susceptible to both oxidative and reducing conditions and therefore it has been exploited in dual redox-responsive PNMs. Here, we review PNMs, mainly reported in the last four years, that contain these redox-responsive moieties for controlled payload release.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33616136     DOI: 10.1039/d0tb02190c

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  3 in total

1.  A Degradable Difunctional Initiator for ATRP That Responds to Hydrogen Peroxide.

Authors:  Lawrence Hill; Hunter Sims; Ngoc Nguyen; Christopher Collins; Jeffery Palmer; Fiona Wasson
Journal:  Polymers (Basel)       Date:  2022-04-24       Impact factor: 4.967

Review 2.  Drug Delivery Systems with a "Tumor-Triggered" Targeting or Intracellular Drug Release Property Based on DePEGylation.

Authors:  Zhe Ren; Tao Liao; Cao Li; Ying Kuang
Journal:  Materials (Basel)       Date:  2022-07-31       Impact factor: 3.748

Review 3.  Recent advances in redox-responsive nanoparticles for combined cancer therapy.

Authors:  Yanjun Yang; Wen Sun
Journal:  Nanoscale Adv       Date:  2022-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.